Skip to content

Clinical trials

Completed Observational Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Observational Status: Completed Clear all

309 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20016
20026
20038
20046
200512
200617
200716
200810
200923
201017
201115
201215
201317
201416
20157
201613
201715
201811
201913
20206
202110
20228
20238
20248
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed309

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)9
Massachusetts General Hospital7
University of Alabama at Birmingham7
Stanford University6
Pennington Biomedical Research Center5
University of Aarhus5
University of Colorado, Denver5
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Odense University Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance309
Obesity86
Diabetes Mellitus, Type 269
Diabetes Mellitus58
Metabolic Syndrome27
Cardiovascular Diseases24
Hypertension23
Inflammation23
Diabetes Mellitus, Type 114
Overweight14

Trials

Showing 1 to 25 of 309. Each trial links to its page on Pharma Observatory.

209 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.